We found 53 results for your search.

Products

…the European Commission as safe and effective. Biosimilars in the EU receive approval only after a long and thorough examination of their registration data, which always includes a full assessment…

How to regulate drug prices in Kazakhstan

…generics for basic therapy, ” says Irina Chublukova, director for the promotion of specialized drugs and market access at SANTO. Pricing practices As already noted, representatives of the industry are…

Master-class “Pharmacological methods for prognosis improvement for patients with chronic cardiac failure”

…specialists and cardiologists: M. Tundybayeva, S. Abseitova, G.Zhusupova, M.Mukarova, G.Alipova, R.Almukhambetova, Sh.Zhangelova, K.Karibayeva participated in panel discussions. —————————————————————————————————————————————— ABOUT SANTO:                                                                     SANTO Member of Polpharma Group is the trademark of…

ACCESS TO BIOLOGICAL THERAPY IN KAZAKHSTAN: REALITY OR FUTURE?

…Astana on May 17. Participants included representatives of regulatory authorities, non-profit organizations, pharmaceutical companies, and clinical experts, who discussed issues regarding regulation, availability and circulation of antibiotics and biosimilars in…